title: [Artificial contrasting during magnetic resonance tomography].
authors.affiliation: Moscow State Medical University.
authors.forename: P V
authors.initials: PV
authors.lastname: Sergeev
authors.forename: O V
authors.initials: OV
authors.lastname: Panov
authors.forename: S V
authors.initials: SV
authors.lastname: Egorova
authors.forename: E N
authors.initials: EN
authors.lastname: Bolotova
authors.forename: N L
authors.initials: NL
authors.lastname: Shimanovskii
authors.forename: T A
authors.initials: TA
authors.lastname: Akhadov
authors.forename: N K
authors.initials: NK
authors.lastname: Sviridov
mesh_terms: D000818:Animals; D003287:Contrast Media / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry; D004333:Drug Administration Routes; D005682:Gadolinium / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry; D019786:Gadolinium DTPA; D006571:Heterocyclic Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008536:Meglumine / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry; D009942:Organometallic Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry; D004369:Pentetic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives / Q000737:chemistry; D012449:Safety
chemical_list: D003287:Contrast Media; D006571:Heterocyclic Compounds; D009942:Organometallic Compounds; C062402:gadoteridol; D008536:Meglumine; D004369:Pentetic Acid; C064925:gadodiamide; D005682:Gadolinium; D019786:Gadolinium DTPA; C072417:gadoterate meglumine